Global Facial Injectables Market Size is Set to Hit $17.2 Billion By 2025: Grand View Research, Inc

September 04 11:14 2019
Global Facial Injectables Market Size is Set to Hit $17.2 Billion By 2025: Grand View Research, Inc

Grand View Research, Inc. – Market Research And Consulting
According to report published by Grand View Research, The global facial injectables market size was valued at USD 6.5 billion in 2016 and is expected to grow at a CAGR of 11.5% during the forecast period.

The global Facial Injectables Market is expected to reach USD 17.2 billion by 2025, according to a new report by Grand View Research, Inc. The market is expected to exhibit lucrative growth during the forecast period, owing to advancements in facial rejuvenation procedures and increasing importance of medical aesthetics across the globe.

Development in products & procedures, as well as change in patient demographics is helping dermatologists and physicians treat multiple facial areas. These advancements help dermatologists or physicians develop customized treatment for patients and facilitate use of combination products to obtain better outcomes. All these factors are expected to assist in the market growth over the forecast period. Augmented products such as Botulinum Toxin Type A (BoNTA) and Hyaluronic Acid (HA) fillers are used in combination to improve outcomes, especially in the lower face procedures. HA fillers are mostly preferred by physicians due to their better acceptance (few instances of hypersensitivity reactions), biodegradable nature, & high viscosity as well as for the longevity they provide to the restored volume.

Minimally invasive surgery, an advanced medical technology, is used for facial rejuvenation, endoscopy, laparoscopy, arthroscopy and other procedures. This procedure is gaining popularity over time owing to faster recovery, low instances of postsurgery infections, lower pain, reduced scarring, and high accuracy & maximum benefits. For instance, as per International Society of Aesthetic Plastic Surgery (ISAPS), more than 20.0 million surgical and nonsurgical cosmetic procedures were performed worldwide in 2014.The number of HA-based surgeries performed in 2014 was 2,690,633, which increased to 2,865,086 in 2015, which is thereby expected to contribute to the growth of this space over the forecast period.

U.S. facial injectables market, by product, 2014 – 2025 (USD Billion)

Facial Injectables Market

Request a Sample Copy of the Global Facial Injectables Market Research Report @ https://www.grandviewresearch.com/industry-analysis/facial-injectables-industry/request/rs1

Further key findings from the study suggest:

  • The hyaluronic acid segment held a lucrative share in 2016 and is expected to grow at a significant rate over the forecast period owing to increasing preference for combination treatments such as hyaluronic acid with BoNTA.
  • The BoNTA segment is anticipated to witness the fastest growth over the forecast period due to increasing application in aesthetics and therapeutics
  • The aesthetics segment is expected to dominate the market during the forecast period owing to increasing expenditure on aesthetic procedures coupled with rising beauty consciousness among consumers
  • North America is expected to dominate the facial injectables market over the forecast period due to growing geriatric population base, increasing consumer disposable income, and surge in number of facial procedures in the region
  • Some of the key players in facial injectables market are ALLERGAN; Ipsen; Merz Pharma; Suneva Medical, Inc.; Medytox, Inc.; Sinclair Pharma; Bloomage BioTechnology Corporation Limited; Anika Therapeutics, Inc.; Prollenium Medical Technologies Inc.; and Galderma S.A.

Global facial injectables market, by application, 2016 (%) 

Global facial injectables market

Have Any Query? Ask Our [email protected] https://www.grandviewresearch.com/inquiry/189/ibb

Grand View Research has segmented the global facial injectables market on the basis of product, application, and region:

Facial Injectables Product Outlook (Revenue, USD Million, 2014 – 2025)

  • Collagen
  • Hyaluronic Acid (HA)
  • Botulinum Toxin Type A
  • Calcium Hydroxylapatite (CaHA)
  • Polymer Fillers
    • Polymethylmethacrylate Beads (PMMA Microspheres)
    • Poly-L-lactic acid (PLLA)

Facial Injectables Application Outlook (Revenue, USD Million, 2014 – 2025)

  • Aesthetics
  • Therapeutics

Facial Injectables Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa (MEA)
    • South Africa

Browse Related Reports @

Facial Implant Market: https://www.grandviewresearch.com/industry-analysis/facial-implant-market

Cosmetic Implants Market: https://www.grandviewresearch.com/industry-analysis/cosmetic-implant-market

About Grand View Research

Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: United States
Website: www.grandviewresearch.com/industry-analysis/facial-injectables-industry

  Categories: